In a double-blind, random-order, cross-over study the effects of placebo and 100 mg of caffeine on postprandial sitting and erect blood pressure and heart rate were studied in 20 frail elderly subjects (mean age 84, range 75-93 years) after a standardized 400 K-calorie glucose drink. Maximal postprandial reduction in sitting systolic blood pressure occurred, at 60 minutes post-placebo, of -11 mmHg (95% confidence interval -5 to -17 mmHg, P<0.01), and was attenuated by caffeine (P<0.05) with changes in systolic blood pressure, at 60 minutes post-drink, of 1 mmHg (95% CI -6 to 7 mmHg, not significant). Four subjects developed symptomatic postprandial hypotension after placebo which was prevented by caffeine. There were no significant changes in erect systolic blood pressure, postural systolic blood pressure change, sitting and erect, diastolic blood pressure and heart rate between treatment phases.
Introduction
Postprandial falls in blood pressure occur in elderly subjects after a meal," 2 the greatest changes occurring after a high carbohydrate intake,3 and in frail, very old subjects. 4 The mechanisms by which changes occur are poorly understood but may be related to increased splanchnic and peripheral blood flow mediated by insulin, vaso-active gastrointestinal hormones,5 or adenosine. 6 Caffeine is a pressor agent and is known to increase blood pressure in the elderly7 possibly by stimulation of the sympathetic nervous system,8 renin angiotensin system,9 or by blocking vasodilatory adenosine receptors.'0 In subjects with autonomic failure, caffeine pre-treatment prevented postprandial hypotension.11 However, in healthy elderly subjects conflicting results have been observed on the effects of caffeine on postprandial blood pressure changes. Caffeine given 60 minutes before food failed to prevent the postprandial fall in blood pressure,'2 but when given after food this fall was attenuated.'3 This difference may be explained by the maximal pharmacological action of caffeine treatment post-meal occurring simultaneously with the maximal hypotensive effect of the meal. These studies have only been undertaken in fit elderly subjects and have only used 'supranormal' dosages of caffeine (200-250 mg) equivalent to three to four cups of coffee.14 As syncope and other problems related to low blood pressure are more common in the frail elderly the present study was performed to evaluate the effects of a lower dose of caffeine (100 mg equivalent to one strong cup of coffee or tea)'4 on postprandial blood pressure changes in frail, very old subjects.
Subjects and methods

Subjects
Twenty subjects participated in the study [10 male, mean age 84 ± 5 (s.d.), range 75-93 years]. Two subjects described symptoms of postural hypotension, although no subjects had a postural fall in systolic blood pressure greater than 20 mmHg recorded one minute after changing from a supine to erect position. A further two subjects described symptoms of light headedness and unsteadiness after ingesting a heavy meal. All subjects were completing a period of rehabilitation after acute admission to the Department of Medicine for the Elderly and were due to be discharged to their own home (15) , residential or nursing home (5) .
Subjects had a series of medical problems; cerebrovascular disease (4), ischaemic heart disease (3), peripheral vascular disease (2) 
Methods
Each subject was studied on two occasions on consecutive days. After overnight abstinence from alcohol, smoking, medication and caffeine, subjects were allowed a light breakfast at 0800 h and investigations were commenced at 1200 h. The study was conducted at their bedside.
Throughout the study all subjects rested in a sitting position. Recordings were taken of blood pressure (BP) and heart rate (HR). Blood pressure was recorded using a Hawksley Random-zero sphygmomanometer (diastolic BP taken at Korotkoff phase V), the mean of two recordings being taken as the actual blood pressure both sitting and after one minute of standing. An electrocardiograph recorded heart rate sitting and erect over a period of 30 seconds. At 1230 h subjects consumed a standardized 400 K-calorie glucose drink (Hycal) over 5 minutes, and, on completion, consumed either caffeinated coffee (Nescafe Blend 37), weighed to contain 100 mg ofcaffeine, or decaffeinated coffee (Nescafe Gold Blend Decaffeinated) dissolved in 100 ml of water in a double-blind, random order, cross-over fashion.
Sitting blood pressure and heart rate recordings were taken for 30 minutes preprandially and at 15 minute intervals for 90 minutes after completion of the meal and coffee drink. Erect blood pressure and heart rate recordings were taken immediately before the meal and every 30 minutes postprandially. Throughout the study subjects were questioned about the development of any new symptoms.
Statistics
All results are expressed as a mean ± one standard error in the mean and 95% confidence intervals (CI) are also given where indicated. The differences between heart rate and blood pressure responses after each test were analysed by calculating the area under the curve (AUC) for that parameter by the trapezoid method giving an overall summary statistic for each subject for the whole study period for that meal and were compared by the paired Wilcoxon signed rank sum test. Baseline and maximum changes were compared by Student's t tests.
Results
All subjects consumed the glucose and coffee drinks on each occasion and no adverse symptoms were reported. Preprandially there was no difference in sitting and erect systolic (SBP), diastolic blood pressure (DBP) or heart rate (HR) in either phase of the study (Table I) .
The sitting blood pressure and HR changes over the study period are shown in Figure 1 . Overall there was a significant difference in the change in sitting SBP between placebo and caffeine phases of the study (P<0.05). After placebo there was an overall decrease in supine SBP of -8 mmHg (95% confidence interval -10 to -6 mmHg, P< 0.01) compared with an increase after caffeine of + 2 mmHg (0 to + 4 mmHg, NS). There was no difference in the changes in DBP between placebo and caffeine, and overall there was a non-significant decrease in DBP after placebo of -6 mmHg (-8 to -3 mmHg) and caffeine of -1 mmHg (-3 to -1 mmHg). There was no overall difference in changes in HR between placebo and caffeine. Overall there was a small increase after both phases of the study of + 5 beats per minute (+ 3 to + 7 beats per minute, P <0.05).
Erect SBP, DBP and HR after placebo and caffeine are shown in Figure 2 . There was no difference in changes in erect SBP between placebo and caffeine phases of the study postprandially. After placebo there was an overall decrease in erect SBP of -6 mmHg (-9 to -3 mmHg, P < 0.05) and after caffeine there was a non-significant decrease of -5 mmHg (-7 to -2 mmHg). There was no overall difference in erect DBP between treatment phases with no significant changes after placebo -2 mmHg (-4 to -1 mmHg) and caffeine of 0 mmHg (-2 to + 1 mmHg). Likewise, there was no overall difference in change in HR between placebo and caffeine; small increases occurred, after placebo of +5 beats per minute (+ 3 to + 7 mmHg, P < 0.05) and after caffeine of + 3 beats per minute ( + 2 to + 5 beats per minute, P<0.05).
Maximum changes in sitting and erect SBP, DBP and HR after placebo and caffeine treatment phases are shown in Table II . Maximum reductions in sitting SBP occurred at 60 minutes postprandially after placebo of -11 mmHg (-17 to -6 mmHg, P < 0.01), whereas at 60 minutes after caffeine there was a change in SBP of + 2 mmHg (-6 to + 7 mmHg, NS). Four subjects described symptoms of lethargy, tiredness and light-headedness after placebo, but not caffeine. In each subject sitting SBP fell to under 100 mmHg with maximum changes of-32 vs -26, -32 vs-10, -28 vs-14, -16 vs -8 mmHg after placebo and caffeine, respectively. Postural changes in SBP, DBP and HR are shown in Table III . There was no overall difference in the change in sitting to erect SBP between placebo and caffeine phases of the study, although in the first 30 minutes after food there was an increase in the postural change in SBP of -1 ± 2 to -4 ± 2 mmHg after placebo compared to a decrease from -4 ± 2 to 0 ± 2 mmHg after caffeine (P<0.01). This difference was mainly due to changes in two subjects who developed symptomatic postural hypotension after placebo, but not caffeine (postural change in systolic SBP >20 mmHg). One of these subjects had previously described symptoms of light-headedness and unsteadiness on standing. There were no overall differences in the postural changes in DBP or HR between placebo and caffeine treatment phases.
Discussion
The results of this study confirm the previous observations of postprandial BP reductions without compensatory increase in heart rate in frail elderly subjects.4 Furthermore, the administration of 100 mg of caffeine attenuated the fall in sitting, but not standing BP.
Previous studies have shown that 200-250 mg of caffeine prevents postprandial hypotension in subjects with autonomic failure8 and in normal healthy elderly.'3 In this study we evaluated the clinical significance of postprandial reductions of blood pressure by studying the subjects most likely to develop adverse symptomatology; the very old and frail with poor mobility, multiple pathology and taking multiple medications. Subjects were given caffeine in a dosage equivalent to a strong drink of coffee thus offering a practical treatment for patients with symptomatic postprandial hypotension. Interestingly, four subjects in this study did develop symptomatic postprandial hypotension which was prevented by caffeine.
The postprandial fall in erect BP was similar to the changes in sitting BP. This result in frail elderly subjects supports the findings in the fit elderly ofno significant postprandial changes in sitting to standing postural tolerance.2"16"7 Two subjects did develop symptomatic postural hypotension (SBP fall > 20 mmHg on standing) after food. However, unlike Robinson et al. we did not observe large postprandial reductions in sitting BP in these two subjects. ' Overall, caffeine did not produce a significant alteration in either erect BP or the postural BP response, but in the two subjects who developed postprandial postural hypotension these changes were prevented by caffeine. It is likely that the mechanisms of postprandial and postural decline in BP are different,'8 but in many elderly there may be a combination of factors (illness, medication, meal and postural change) which may interact and produce syncope.
In summary, a lower dose of caffeine (100 mg equivalent to one strong cup of coffee or tea) attenuates the postprandial fall in sitting, but not standing BP in frail elderly subjects. In particular, caffeine prevented both symptoms and BP changes in all 4 subjects with postprandial hypotension and 2 subjects with postural hypotension. Future studies should be directed to investigate the effects of caffeine in these problem groups of patients.
